The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a multi-organ damage that includes hepatic dysfunction, which has been observed in over 50% of COVID-19 patients. Liver injury in COVID-19 could be attributed to the cytopathic effects, exacerbated immune responses or treatment-associated drug toxicity. Herein we demonstrate that hepatocytes are susceptible to infection in different models: primary hepatocytes derived from humanized angiotensin-converting enzyme-2 mice (hACE2) and primary human hepatocytes. Pseudotyped viral particles expressing the full-length spike of SARS-CoV-2 and recombinant receptor binding domain (RBD) bind to ACE2 expressed by hepatocytes, promoting metabolic reprogramming towards glycolysis but also impaired mitochondrial activity. Human and hACE2 primary hepatocytes, where steatosis and inflammation were induced by methionine and choline deprivation, are more vulnerable to infection. Inhibition of the renin-angiotensin system increases the susceptibility of primary hepatocytes to infection with pseudotyped viral particles. Metformin, a common therapeutic option for hyperglycemia in type 2 diabetes patients known to partially attenuate fatty liver, reduces the infection of human and hACE2 hepatocytes. In summary, we provide evidence that hepatocytes are amenable to infection with SARS-CoV-2 pseudovirus, and we propose that metformin could be a therapeutic option to attenuate infection by SARS-CoV-2 in patients with fatty liver.

Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19

“…The whole-cell lysate was used to evaluate the levels of ATP using the ATPlite Luminescence Assay System, 300 Assay Kit (catalog no. 6016943; Perkin Elmer, Seer Green, UK), following the manufacturer’s instructions and normalized to total protein levels, as described previously [ 17 ].…”

PPARγ mediated enhanced lipid biogenesis fuelsMycobacterium tuberculosisgrowth in hepatocytes

“…Several recent publications directly correlate infection of hepatocytes with hyperglycaemia[44, 45] . With multiple reports correlating hepatic steatosis with the onset of Type 2 Diabetes Mellitus (T2DM), it can be hypothesized that TB-induced hepatic steatosis might predispose TB patients to T2DM and other metabolic disorders.…”

COVID-19-Induced Diabetes Mellitus: Comprehensive Cellular and Molecular Mechanistic Insights

“…This, therefore, can, in part, explain the hyperglycaemia observed in COVID-19. Mechanistically, molecular analysis suggests the virus promotes the activity of the key gluconeogenic enzyme, phosphoenolpyruvate kinase (PEPCK) [ 62 ]. PEPCK is a rate-limiting enzyme that is inhibited by insulin whilst stimulated by glucagon and other hormones, including glucocorticoids and catecholamines.…”

“…Furthermore, studies have reported increases in lactate dehydrogenase over pyruvate dehydrogenase, further supporting the metabolic shift toward hyperglycolysis [ 67 ]. From a biochemical perspective, favouring hyperglycolytic pathways could ensure the sustainable production of lactate [ 62 ]. Lactate, amongst other metabolic substrates, including alanine and glutamates, are the main precursors for glucose in gluconeogenesis.…”